Arax Advisory Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.53K	Buy	505 +459	+998%	+$3.56K	﹤0.01%	2826
2025 Q4	$359	Sell	46 -2,947	-98%	-$21.3K	﹤0.01%	3650
2025 Q3	$22.7K	Buy	2,993 +2,290	+326%	+$19.1K	﹤0.01%	2204
2025 Q2	$6.3K	Sell	703 -408	-37%	-$3.8K	﹤0.01%	2152
2025 Q1	$8.33K	Buy	1,111 +373	+51%	+$3.01K	﹤0.01%	1619
2024 Q4	$5.55K	Hold	738	–	–	﹤0.01%	1706
2024 Q3	$5.61K	Sell	738 -40	-5%	-$304	﹤0.01%	1667
2024 Q2	$4.81K	Buy	778 +694	+826%	+$3.83K	﹤0.01%	1614
2024 Q1	$426	Buy	84 +32	+62%	+$180	﹤0.01%	1244
2023 Q4	$312	Hold	52	–	–	﹤0.01%	1255
2023 Q3	$368	Hold	52	–	–	﹤0.01%	1260
2023 Q2	$367	Buy	52 +1	+2%	+$8	﹤0.01%	1225
2023 Q1	$426	Buy	51 +13	+34%	+$125	﹤0.01%	1212
2022 Q4	$436	Buy	+38	New	+$474	﹤0.01%	1194